Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merlin Biomed Group is a specialized investment management firm focused exclusively on the healthcare and life sciences sectors. Founded in 1998 by Dr. Ron Laufer, the firm manages a range of investment vehicles, including hedge funds and private equity funds, that target innovative biotechnology, pharmaceutical, and medical technology companies. The group utilizes a deep scientific and clinical approach to identify high-growth opportunities within the global healthcare market. Merlin Biomed provides strategic capital and expertise to both public and private entities, aiming to drive value through medical innovation. The firm is recognized for its expertise in healthcare long/short equity strategies and has been a significant participant in the biotech investment landscape for over two decades.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merlin Biomed Group.